Table 3.
Control study group |
||
---|---|---|
QUICKI ≥ 0.357 n = 175 |
QUICKI < 0.357 n = 79 |
|
Age (years) | 35.6 ± 11.3 | 34.6 ± 11.5 |
BMI (kg/m2) | 25.4 ± 3.7 | 28.8 ± 5.2* |
SBP (mm Hg) | 101.2 ± 11.9 | 103.2 ± 10.5 |
DBP (mm Hg) | 68.1 ± 8.3 | 70.4 ± 7.4** |
Gluc0h (mg/dL) | 86.6 ± 6.5 | 91.3 ± 5.3* |
Gluc2h (mg/dL) | 99.7 ± 19.5 | 108.1 ± 15.7** |
Ins0h (μU/mL) | 4.7 ± 1.5 | 9.7 ± 2.8*** |
Ins2h (μU/mL) | 33.0 ± 20.8 | 60.4 ± 29.9*** |
HOMA-IR | 1.0 ± 0.3 | 2.2 ± 0.6*** |
HOMA-β | 77.0 ± 36.3 | 132.2 ± 69.5*** |
TC (mg/dL) | 182.9 ± 35.8 | 181.6 ± 34.1 |
HDL-C (mg/dL) | 50.0 ± 12.9 | 42.7 ± 10.2* |
TAG (mg/dL) | 92.4 ± 29.7 | 102.8 ± 29.7* |
TAG/HDL-C | 2.0 ± 0.8 | 2.6 ± 1.0*** |
CVI | 3.8 ± 0.9 | 4.4 ± 0.9* |
Notes: Results are expressed as mean ± standard deviation.
P # 0.05, Kruskal–Wallis one-way analysis of variance;
P # 0.05, one-way analysis of variance;
P # 0.05, Mann–Whitney U test.
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Glc0h, fasting glucose; Gluc2h, Glucose 2 hours after a 75-g of glucose oral load; Ins0h, fasting insulin; Ins2h, insulin 2 hours after 75-g of oral glucose load; TC, total cholesterol; HDL-C, cholesterol combined with high-density lipoprotein; TAG, triacylglycerides; HOMA-IR, homeostatic model assessment of insulin resistance; HOMA-β, homeostatic model assessment of β-cell function; QUICKI, index to check the quantitative insulin sensitivity; FH-T2D, family history of type 2 diabetes mellitus; CVI, Castelli Cardiovascular Index.